重庆太极实业（集团）股份有限公司 股东会议事规则 （2025 年 7 月修订） 第一章 总 则 第一条 为规范重庆太极实业（集团）股份有限公司（以 下简称公司）行为，保证股东会依法行使职权，根据《中华 人民共和国公司法》（以下简称《公司法》）、《中华人民共和 国证券法》（以下简称《证券法》）、《上市公司治理准则（2025 年修正）》《上市公司股东会规则》《上海证券交易所股票上 市规则（2025 年 4 月修订）》（以下简称《上市规则》）、《重 庆太极实业（集团）股份有限公司章程》（以下简称《公司 章程》）、《上海证券交易所上市公司自律监管指引第 1 号— 规范运作（2025 年 5 月修订）》及其他有关法律法规的规定， 制定本规则。 第二条 公司股东会的召集、提案、通知、召开等事项 适用本规则。 第三条 公司应当严格按照法律、行政法规、本规则及 《公司章程》的相关规定召开股东会，保证股东能够依法行 使权利。 （二）出席会议人员的资格、召集人资格是否合法有效； （三）会议的表决程序、表决结果是否合法有效； 公司董事会应当切实履行职责，认真、按时组织股东会。 公司全体董事应当勤勉尽责，确保股东会正常召开和依法行 ...

重庆太极实业（集团）股份有限公司 董事会议事规则 （2025 年 7 月修订） 第一章 总 则 第一条 为进一步规范重庆太极实业（集团）股份有限 公司（以下简称"公司"）董事会议事方式和决策程序，促 使董事和董事会有效地履行其职责，确保董事会规范、高效 运作和审慎、科学决策，根据《中华人民共和国公司法》（以 下简称《公司法》）、《中华人民共和国证券法》（以下简称《证 券法》）、《上市公司治理准则（2025 年修正）》《上海证券交 易所股票上市规则（2025 年 4 月修订）》（以下简称《上市规 则》）、《上海证券交易所上市公司自律监管指引第 1 号—规 范运作（2025 年 5 月修订）》《重庆太极实业（集团）股份有 限公司章程》（以下简称《公司章程》）等有关规定，制定本 规则。 第二条 董事会下设董事会办公室（即公司证券与投资 部），处理董事会日常事务。 董事会秘书或证券事务代表兼任证券与投资部负责人， 董事会秘书可以指定证券事务代表等有关人员协助其处理 日常事务。 第三条 本规则适用于公司董事会、董事会专门委员会、 董事及本规则中涉及的有关人员。 第四条 董事会行使下列职权： （一）召集股东会，并向股东会 ...

证券代码：600129 证券简称：太极集团 公告编号：2025-047 重庆太极实业（集团）股份有限公司 关于增补董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重庆太极实业（集团）股份有限公司（以下简称：公司）于 2025 年 7 月 7 日召开了第十届董事会第二十九次会议，审议通过了《关于 增补公司董事的议案》。 根据《公司法》和《公司章程》的有关规定，经公司控股股东太 极集团有限公司推荐，同意余星玥女士作为公司第十届董事会董事候 选人，任期自股东大会审议通过之日起至第十届董事会届满时止（简 历附后）。 附：余星玥女士个人简历 上述议案在提交董事会审议前，已经公司第十届董事会提名委员 会会议审议通过。 余星玥，女，1988 年出生，中共党员，重庆交通大学机械设计 制造及自动化/工程造价管理专业本科，高级经济师、二级建造师。 曾任重庆市涪陵国有资产投资经营集团有限公司项目管理部副经理， 现任重庆市涪陵国有资产投资经营集团有限公司项目管理部经理。 截至本公告披露日，余星玥女士未持有公司股份；与公司董事、 监事、高 ...

证券代码：600129 证券简称：太极集团 公告编号：2025-045 重庆太极实业（集团）股份有限公司 第十届监事会第二十四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重庆太极实业（集团）股份有限公司（以下简称：公司）第十届监 事会第二十四次会议于 2025 年 6 月 27 日以邮件方式发出书面通知， 于 2025 年 7 月 7 日以现场及视频方式召开。会议应到监事 3 人，实到 监事 3 人，公司董事会秘书列席了会议。本次会议的召集、召开程序符 合《公司法》和《公司章程》的有关规定，会议合法有效。会议审议并 通过了如下议案： 一、关于变更会计师事务所的议案（具体内容详见公司披露的《关 于变更会计师事务所的公告》；公告编号 2025-046） 鉴于原审计机构天健会计师事务所（特殊普通合伙）服务期限已 满，根据《国有企业、上市公司选聘会计师事务所管理办法》（财会 〔2023〕4 号）等相关规定，为保证审计工作的独立性和客观性，经 公司邀请招标，拟聘任立信会计师事务所（特殊普通合伙）为公司 2025 年 ...

Core Viewpoint - China National Pharmaceutical Group Corporation (Sinopharm Group) is facing significant challenges with Taiji Group, which has experienced a dramatic decline in performance after a strong 2023, with a 20.72% drop in revenue and a 96.76% plunge in net profit in 2024 [1][3][9] Financial Performance - In 2024, Taiji Group's total revenue decreased by 20.72% to 12.386 billion yuan, while net profit fell by 96.76% to 26.6527 million yuan [1][3] - The company's net profit for 2024 was revised to reflect a 96.76% decline, significantly impacted by tax liabilities from subsidiaries [9][10] - Quarterly performance showed a severe drop in net profit, particularly in Q4, which contributed to the overall annual decline [4][5] Product Performance - Key products like Huoxiang Zhengqi Oral Liquid saw a sharp decline in sales, with 2024 sales volumes dropping to 96 million boxes from 231 million boxes in 2023 [8] - Other products also experienced significant sales declines, while only a few, such as sinusitis oral liquid, showed growth [8] Management and Governance - Recent personnel changes in the board of directors, with several resignations and new appointments from Sinopharm Group, indicate a shift in management strategy [5][6] - The effectiveness of the new management in reversing the company's fortunes remains uncertain as the deadline for resolving industry competition issues approaches [10] Strategic Challenges - The company is struggling with an aging product portfolio and has not introduced new blockbuster drugs in over a decade, relying heavily on existing products [8] - The upcoming deadline for Sinopharm Group's commitment to resolve competition issues poses additional pressure on Taiji Group to meet its revenue targets for the 14th Five-Year Plan [10]

Core Viewpoint - The company, Taiji Group, is facing significant challenges, including a substantial decline in stock price and concerns regarding management's effectiveness in addressing competition and improving performance [2][3]. Group 1: Stock Performance - As of June 27, 2025, Taiji Group's stock closed at 21.22 yuan, down 0.52%, with a turnover rate of 1.49% and a trading volume of 83,100 shares, amounting to a transaction value of 177 million yuan [1]. - Over the past year and a half, the stock price has decreased by more than 70% [3]. Group 2: Management and Strategy - The management team is focusing on a strategy of "two focuses, two innovations" aimed at strengthening and optimizing major traditional Chinese medicine products, emphasizing technological and marketing innovations to drive performance recovery [2]. - The actual controller of the company has committed to resolving competition issues through various means, including asset swaps and management changes, while ensuring no new competition arises [3]. Group 3: Investor Communication - The company adheres to information confidentiality and fairness principles, stating that shareholder numbers and major shareholders will only be disclosed in regular reports [2]. - The company has received inquiries from investors regarding the management's actions and the commitment to resolving competition issues, indicating a need for clearer communication and transparency [3]. Group 4: Trading Information - On June 27, the net outflow of main funds was 18.81 million yuan, accounting for 10.64% of the total transaction value [4]. - Retail investors showed a net inflow of 3.59 million yuan, representing 2.03% of the total transaction value [5].

| 000538 | 云南白药 | -0.02 | 0.29 | -464.02 | | --- | --- | --- | --- | --- | | 603195 | 公牛集团 | -3.31 | 0.27 | -294.27 | | 000599 | 青岛双星 | 1.20 | 1.94 | -269.88 | | 603031 | 安孚科技 | 0.68 | 0.92 | -259.74 | | 603043 | 广州酒家 | -0.84 | 0.32 | -234.96 | | 002820 | 桂发祥 | 2.19 | 2.89 | -64.03 | | 600305 | 恒顺醋业 | 0.26 | 0.46 | 1.38 | | 603156 | 养元饮品 | -1.67 | 0.17 | 8.65 | | 001328 | 登康口腔 | 2.08 | 5.37 | 12.71 | | 002568 | 百润股份 | 0.53 | 1.34 | 13.18 | | 300999 | 金龙鱼 | 0.94 | 0.78 | 37.38 | | 000100 | TCL科技 | -0.46 | 0. ...

证券代码：600129 证券简称：太极集团 公告编号：2025-043 重庆太极实业（集团）股份有限公司 关于获得政府补助的公告 特此公告。 重庆太极实业（集团）股份有限公司 2025 年 6 月 18 日 近日，重庆太极实业（集团）股份有限公司（以下简称：公司） 控股子公司太极集团重庆桐君阁药厂有限公司收到与收益相关的政 府补助 2,000 万元，占公司 2024 年度归属于上市公司股东净利润的 75.04%。 二、补助的类型及其对上市公司的影响 根据《企业会计准则第 16 号-政府补助》的相关规定，上述政府 补助款项属于与收益相关的政府补助，将对公司 2025 年度的净利润 产生积极影响，具体会计处理及其对公司利润的影响，最终以会计师 事务所审计确认后的结果为准。敬请广大投资者注意投资风险。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 一、获得补助的基本情况 ...

Group 1 - Company Xi Zhong Technology proposed to repurchase shares worth between 75 million and 150 million yuan using excess funds and self-owned funds [1] - Company Yongxi Electronics expects a revenue growth of 16.6% to 28.88% in the first half of the year, with projected revenue between 1.9 billion and 2.1 billion yuan [2] - Company Jingyi Equipment anticipates a revenue increase of 36.54% to 42.48%, with expected revenue between 690 million and 720 million yuan [2][3] Group 2 - Company Haipuri received approval from the European Medicines Agency (EMA) for a new production line for Enoxaparin Sodium injection, with an annual capacity of 330 million doses [4] - Company Inner Mongolia Xinhua plans to merge its wholly-owned subsidiaries to optimize resource allocation and improve operational efficiency [5] - Company Cloud Chemical intends to sign daily related transaction framework agreements with its controlling shareholder to reduce operational costs [7] Group 3 - Company China Software received approval from the China Securities Regulatory Commission for a specific stock issuance [8] - Company Wankong Intelligent's subsidiary won a bid for a project with the State Grid worth approximately 12.17 million yuan [9] - Company Lianlong obtained a patent for an anti-aging agent, which is expected to enhance its product offerings in polymer materials [11] Group 4 - Company Yunlu plans to increase its shares by 4 million to 12 million yuan through stock purchases by its executives [12] - Company Enhua Pharmaceutical's chairman increased his stake by 237,900 shares [14] - Company Daqin Railway announced the resignation of its general manager due to retirement [15] Group 5 - Company Hefei Urban Construction signed a land use rights transfer contract for an industrial site with an area of 78,561.78 square meters, with a payment of 103 million yuan due by July 13, 2025 [16] - Company Taiji Group received a government subsidy of 20 million yuan, representing 75.04% of its projected net profit for 2024 [17] - Company Guodian Nanrui elected a new chairman, Zheng Zongqiang, while he resigned from his previous roles [19] Group 6 - Company Xinhua Medical received a medical device registration certificate for a thromboelastography testing kit [20] - Company Baotailong's subsidiary obtained a mining license for a graphite mine with a production capacity of 2 million tons per year [21] - Company Zejing Pharmaceutical received approval for clinical trials of its innovative cancer treatment drugs [22] Group 7 - Company Aojing Medical's artificial bone repair material received registration approval in Vietnam [23] - Company Chengjian Development received a cash dividend of 90.2169 million yuan from Guoxin Securities [24] - Company Rili Technology proposed a share repurchase plan worth between 10 million and 20 million yuan [25] Group 8 - Company Deshi General Institute received approval to issue up to 1 billion yuan in technology innovation bonds [44] - Company Tongding Interconnect plans to bid for two procurement projects worth approximately 717 million yuan [46] - Company Bangji Technology plans to acquire multiple agricultural companies [46]

证券代码：600129 证券简称：太极集团 公告编号：2025-042 重庆太极实业（集团）股份有限公司 关于公司控股股东股权解押及质押的公告 | 行 | | | | | 转提 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 公司 | | | | | | | | | | | | | | | 供担 | | | | | | | | | | | | | | | 保 | | | | | | | | | | | | | | | 合计 | | 534 | | | | | | | | | 3.47% | | 0.96% | | | | 或其他保障用途。 | | | | | | | | | | | | | | | | | | | 截至公告披露日，上述股东及其一致行动人累计质押股份情况如 | | | | | | | | | | 下: | | | | | | | | | | | | | | | | | | | | | | | | 已质押股份 | | | 未质 | | ...